Page last updated: 2024-09-03

imatinib mesylate and Adenoma

imatinib mesylate has been researched along with Adenoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Björk, J; Classon, J; Clevers, H; Frisén, J; Genander, M; Kundu, P; Martling, A; Pettersson, S; Ridgway, RA; Sansom, OJ; Strååt, K; Tan, EH; van Es, J	1
Durie, N; Kesterson, J; Lele, S; Mhawech-Fauceglia, P; Syriac, S	1
Gräter, H	1

Reviews

1 review(s) available for imatinib mesylate and Adenoma

Article	Year
[Tumors of the small intestine]. Praxis, 2002, Oct-09, Volume: 91, Issue:41 Topics: Adenocarcinoma; Adenoma; Adenomatous Polyposis Coli; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Diagnosis, Differential; Duodenal Neoplasms; Genetic Predisposition to Disease; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Risk	2002

Article

Year

[Tumors of the small intestine].

Praxis, 2002, Oct-09, Volume: 91, Issue:41

Topics: Adenocarcinoma; Adenoma; Adenomatous Polyposis Coli; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Diagnosis, Differential; Duodenal Neoplasms; Genetic Predisposition to Disease; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Risk

2002

Other Studies

2 other study(ies) available for imatinib mesylate and Adenoma

Article	Year
An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth. Science translational medicine, 2015, Apr-01, Volume: 7, Issue:281 Topics: Adenoma; Animals; Carcinogenesis; Cell Proliferation; Ephrin-B2; Genes, APC; Imatinib Mesylate; Intestinal Neoplasms; Longevity; Mice; Proto-Oncogene Proteins c-abl; Signal Transduction; Tumor Suppressor Proteins	2015
Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2011, Volume: 30, Issue:3 Topics: Adenoma; Adnexal Diseases; Adult; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Breast Neoplasms; Broad Ligament; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Ovarian Neoplasms; Piperazines; Polymerase Chain Reaction; Pyrimidines; Selective Estrogen Receptor Modulators; Tamoxifen	2011

Article

Year

An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth.

Science translational medicine, 2015, Apr-01, Volume: 7, Issue:281

Topics: Adenoma; Animals; Carcinogenesis; Cell Proliferation; Ephrin-B2; Genes, APC; Imatinib Mesylate; Intestinal Neoplasms; Longevity; Mice; Proto-Oncogene Proteins c-abl; Signal Transduction; Tumor Suppressor Proteins

2015

Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2011, Volume: 30, Issue:3

Topics: Adenoma; Adnexal Diseases; Adult; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Breast Neoplasms; Broad Ligament; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Ovarian Neoplasms; Piperazines; Polymerase Chain Reaction; Pyrimidines; Selective Estrogen Receptor Modulators; Tamoxifen

2011